438 related articles for article (PubMed ID: 21039332)
1. ABC subfamily D proteins and very long chain fatty acid metabolism as novel targets in adrenoleukodystrophy.
Morita M; Shimozawa N; Kashiwayama Y; Suzuki Y; Imanaka T
Curr Drug Targets; 2011 May; 12(5):694-706. PubMed ID: 21039332
[TBL] [Abstract][Full Text] [Related]
2. Impaired very long-chain acyl-CoA β-oxidation in human X-linked adrenoleukodystrophy fibroblasts is a direct consequence of ABCD1 transporter dysfunction.
Wiesinger C; Kunze M; Regelsberger G; Forss-Petter S; Berger J
J Biol Chem; 2013 Jun; 288(26):19269-79. PubMed ID: 23671276
[TBL] [Abstract][Full Text] [Related]
3. Peroxisomal ABC transporters: structure, function and role in disease.
Morita M; Imanaka T
Biochim Biophys Acta; 2012 Sep; 1822(9):1387-96. PubMed ID: 22366764
[TBL] [Abstract][Full Text] [Related]
4. [Adrenoleukodystrophy: structure and function of ALDP, and intracellular behavior of mutant ALDP with naturally occurring missense mutations].
Takahashi N; Morita M; Imanaka T
Yakugaku Zasshi; 2007 Jan; 127(1):163-72. PubMed ID: 17202797
[TBL] [Abstract][Full Text] [Related]
5. Differential substrate specificities of human ABCD1 and ABCD2 in peroxisomal fatty acid β-oxidation.
van Roermund CW; Visser WF; Ijlst L; Waterham HR; Wanders RJ
Biochim Biophys Acta; 2011 Mar; 1811(3):148-52. PubMed ID: 21145416
[TBL] [Abstract][Full Text] [Related]
6. X-linked adrenoleukodystrophy: very long-chain fatty acid metabolism is severely impaired in monocytes but not in lymphocytes.
Weber FD; Wiesinger C; Forss-Petter S; Regelsberger G; Einwich A; Weber WH; Köhler W; Stockinger H; Berger J
Hum Mol Genet; 2014 May; 23(10):2542-50. PubMed ID: 24363066
[TBL] [Abstract][Full Text] [Related]
7. Abcd2 is a strong modifier of the metabolic impairments in peritoneal macrophages of ABCD1-deficient mice.
Muneer Z; Wiesinger C; Voigtländer T; Werner HB; Berger J; Forss-Petter S
PLoS One; 2014; 9(9):e108655. PubMed ID: 25255441
[TBL] [Abstract][Full Text] [Related]
8. The human peroxisomal ABC half transporter ALDP functions as a homodimer and accepts acyl-CoA esters.
van Roermund CW; Visser WF; Ijlst L; van Cruchten A; Boek M; Kulik W; Waterham HR; Wanders RJ
FASEB J; 2008 Dec; 22(12):4201-8. PubMed ID: 18757502
[TBL] [Abstract][Full Text] [Related]
9. [Adrenoleukodystrophy: molecular pathogenesis and development of therapeutic agents].
Morita M
Yakugaku Zasshi; 2007 Jul; 127(7):1059-64. PubMed ID: 17603264
[TBL] [Abstract][Full Text] [Related]
10. HDAC inhibitor SAHA normalizes the levels of VLCFAs in human skin fibroblasts from X-ALD patients and downregulates the expression of proinflammatory cytokines in Abcd1/2-silenced mouse astrocytes.
Singh J; Khan M; Singh I
J Lipid Res; 2011 Nov; 52(11):2056-69. PubMed ID: 21891797
[TBL] [Abstract][Full Text] [Related]
11. Substrate specificity overlap and interaction between adrenoleukodystrophy protein (ALDP/ABCD1) and adrenoleukodystrophy-related protein (ALDRP/ABCD2).
Genin EC; Geillon F; Gondcaille C; Athias A; Gambert P; Trompier D; Savary S
J Biol Chem; 2011 Mar; 286(10):8075-8084. PubMed ID: 21209459
[TBL] [Abstract][Full Text] [Related]
12. Adrenoleukodystrophy-related protein can compensate functionally for adrenoleukodystrophy protein deficiency (X-ALD): implications for therapy.
Netik A; Forss-Petter S; Holzinger A; Molzer B; Unterrainer G; Berger J
Hum Mol Genet; 1999 May; 8(5):907-13. PubMed ID: 10196381
[TBL] [Abstract][Full Text] [Related]
13. Homo- and heterodimerization of peroxisomal ATP-binding cassette half-transporters.
Liu LX; Janvier K; Berteaux-Lecellier V; Cartier N; Benarous R; Aubourg P
J Biol Chem; 1999 Nov; 274(46):32738-43. PubMed ID: 10551832
[TBL] [Abstract][Full Text] [Related]
14. Co-expression of mutated and normal adrenoleukodystrophy protein reduces protein function: implications for gene therapy of X-linked adrenoleukodystrophy.
Unterrainer G; Molzer B; Forss-Petter S; Berger J
Hum Mol Genet; 2000 Nov; 9(18):2609-16. PubMed ID: 11063720
[TBL] [Abstract][Full Text] [Related]
15. X-linked adrenoleukodystrophy: very long-chain fatty acid metabolism, ABC half-transporters and the complicated route to treatment.
Kemp S; Wanders RJ
Mol Genet Metab; 2007 Mar; 90(3):268-76. PubMed ID: 17092750
[TBL] [Abstract][Full Text] [Related]
16. Biochemical aspects of X-linked adrenoleukodystrophy.
Kemp S; Wanders R
Brain Pathol; 2010 Jul; 20(4):831-7. PubMed ID: 20626744
[TBL] [Abstract][Full Text] [Related]
17. Peroxisomal ABC Transporters: An Update.
Tawbeh A; Gondcaille C; Trompier D; Savary S
Int J Mol Sci; 2021 Jun; 22(11):. PubMed ID: 34198763
[TBL] [Abstract][Full Text] [Related]
18. ABC Transporter Subfamily D: Distinct Differences in Behavior between ABCD1-3 and ABCD4 in Subcellular Localization, Function, and Human Disease.
Kawaguchi K; Morita M
Biomed Res Int; 2016; 2016():6786245. PubMed ID: 27766264
[TBL] [Abstract][Full Text] [Related]
19. Peroxisomal fatty acid uptake mechanism in Saccharomyces cerevisiae.
van Roermund CW; Ijlst L; Majczak W; Waterham HR; Folkerts H; Wanders RJ; Hellingwerf KJ
J Biol Chem; 2012 Jun; 287(24):20144-53. PubMed ID: 22493507
[TBL] [Abstract][Full Text] [Related]
20. Cholesterol regulates ABCD2 expression: implications for the therapy of X-linked adrenoleukodystrophy.
Weinhofer I; Forss-Petter S; Zigman M; Berger J
Hum Mol Genet; 2002 Oct; 11(22):2701-8. PubMed ID: 12374760
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
